Literature DB >> 7518035

An analysis of sequence variation in the beta chain framework and complementarity determining regions of an allo-reactive T cell receptor.

D L DiGiusto1, E Palmer.   

Abstract

Current models of T cell receptor (TCR) structure are generally based on the homology observed between the TCR and the immunoglobulins. Furthermore, these models have predicted the locations of framework and complementarity determining regions within the alpha- and beta-chain variable regions. In order to test the validity of these models, we have generated a series of mutations within the V beta domain of an allo-reactive TCR and determined their effect on antigen recognition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518035     DOI: 10.1016/0161-5890(94)90179-1

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  4 in total

1.  The T cell receptor's alpha-chain connecting peptide motif promotes close approximation of the CD8 coreceptor allowing efficient signal initiation.

Authors:  Michel Mallaun; Dieter Naeher; Mark A Daniels; Pia P Yachi; Barbara Hausmann; Immanuel F Luescher; Nicholas R J Gascoigne; Ed Palmer
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

2.  Molecular modeling of a T-cell receptor bound to a major histocompatibility complex molecule: implications for T-cell recognition.

Authors:  J C Almagro; E Vargas-Madrazo; F Lara-Ochoa; E Horjales
Journal:  Protein Sci       Date:  1995-09       Impact factor: 6.725

3.  Signaling efficiency of the T cell receptor controlled by a single amino acid in the beta chain constant region.

Authors:  B T Bäckström; B T Hausmann; E Palmer
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

4.  Recognition of synthetic polyanionic ligands underlies "spontaneous" reactivity of Vγ1 γδTCRs.

Authors:  Josefine Dunst; Vassilis Glaros; Lukas Englmaier; Patrick A Sandoz; Björn Önfelt; Jan Kisielow; Taras Kreslavsky
Journal:  J Leukoc Biol       Date:  2020-01-13       Impact factor: 4.962

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.